LEO: Tax-Free Yield And Measured Duration Exposure
BNY Mellon Strategic Municipals, Inc. is a closed-end fund primarily investing in investment-grade m…
seekingalpha.com
INSM(INSM)
INSM
Earnings in 4 days · May 7, 2026 · Before open
Signal
Bearish Setup2↓
PRICE
Prev Close
136.33
Open
135.65
Day Range132.39 – 137.62
132.39
137.62
52W Range63.81 – 212.75
63.81
212.75
47% of range
VOLUME & SIZE
Avg Volume
2.2M
FUNDAMENTALS
P/E Ratio
-20.8x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.28
Market-like
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +67% YoY · 79% gross marginValuation
FAIR
P/E not availableHealth
WEAK
CR 3.8 · FCF negativeLean Bullish
Key MetricsTTM
Market Cap$28.76B
Revenue TTM$606.42M
Net Income TTM-$1.28B
Free Cash Flow-$997.58M
Gross Margin79.4%
Net Margin-210.5%
Operating Margin-194.0%
Return on Equity-168.4%
Return on Assets-56.4%
Debt / Equity1.04
Current Ratio3.83
EPS TTM$-5.98
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
2 strong1 watch3 concern
40/100Liquidity
3.83Strong
Leverage
1.04Watch
Coverage
-14.0xConcern
ROE
-168.4%Concern
ROIC
-64.8%Concern
Cash
$510MStrong
ANALYST COVERAGE35 analysts
BUY
▲ +60.2%upside to target
L $166.00
Med $213.50consensus
H $269.00Stock Health
Composite Score
2 of 4 signals bullish
5/10
Technicals
●
✗RSI RangeRSI 44 — Bearish momentum
Fundamentals
●
✗Last EarningsMissed estimates
●
✓Analyst ConsensusBuy
●
✓LiquidityCurrent Ratio 3.83 — healthy liquidity
1 signal unavailable — limited data for this stock
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 17, 2026
In 106 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
▼ DowntrendGolden Cross · 50D leads 200D by 28.4%
-24.3% vs SMA 50 · -2.7% vs SMA 200
Momentum
RSI43.8Momentum fading
MACD-4.39Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$212.8+59.7%
EMA 50
$168.2+26.2%
EMA 200
$134.2+0.7%
Current
$133.3
52W Low
$63.81-52.1%
52-Week RangeMid-range
$63.8147th %ile$212.8
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 15 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $582.4M $581.9M–$582.8M | — | -$5.85 | — | ±10% | High13 |
FY2026(current) | $1.7B $1.6B–$1.8B | ▲ +193.3% | -$2.59 | — | ±50% | High15 |
FY2027 | $2.8B $2.5B–$3.1B | ▲ +66.0% | $1.13 | — | ±50% | High15 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryINSM
Last 8Q
-21.6%avg beat
Beat 1 of 8 quartersMissed 7↓ Estimates falling+15%
Q2'24
-56%
Q3'24
-6%
Q4'24
-13%
Q1'25
-6%
Q2'25
-31%
Q3'25
-32%
Q4'25
-44%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightAnalyst Activity
All ratings →No recent activity
CitigroupBuy
Jun 10
UPGRADE
Zacks Investment Re…Sell
Apr 26
DOWNGRADE
Insider Activity
SEC Filings →0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $3.3M sold · 30d window
Lewis WilliamDir
$321K
Apr 16
SELL
Lewis WilliamDir
$773K
Apr 16
SELL
Lewis WilliamDir
$326K
Apr 16
SELL
Lewis WilliamDir
$120K
Apr 16
SELL
Lewis WilliamDir
$127K
Apr 6
SELL
Lewis WilliamDir
$1.4M
Apr 6
SELL
Financials
INSTITUTIONAL OWNERSHIP
1
Pictet Asset Management Holding SA
1.1M▲2
Nuveen, LLC
535K▼3
Sumitomo Mitsui Trust Holdings, Inc.
501K▲4
Candriam S.C.A.
402K▲5
GATEWAY INVESTMENT ADVISERS LLC
365K—6
ProShare Advisors LLC
283K▼7
abrdn plc
277K▲8
Perpetual Ltd
143K▲News & Activity
INSM News
20 articles · 4h ago
Melco Resorts: Q1 2026 Earnings Confirms Our Bullish Case
seekingalpha.com
Israel approves plan to buy F-35 and F-15I aircraft from US
reuters.com
EgyptAir Takes Delivery of First Boeing 737 MAX Jet
prnewswire.com
Robinhood's Crypto Revenue Took a Hit. Is the Long-Term Story Still Intact?
fool.com
American Express: The Subscription Moat With A Potential AI Bonus On Top
seekingalpha.com
My Top 2 Industrial Stocks for the Iran War Era
fool.com
AI chatbot fraud: the ‘gift card' subcription that may cost you dear
theguardian.com
Tyler Technologies: Encouraging Recovery In Bookings (Rating Upgrade)
seekingalpha.com
Why ServiceNow Stock Fell 16% in April
fool.com
Hamilton Insurance: Rally Has Largely Closed The Valuation Gap (Rating Downgrade)
seekingalpha.com
Cardinal Health Among 9 Companies To Announce Dividend Increases In The First Half Of May
seekingalpha.com
Why Nike Stock Lost 16% in April
fool.com
Denali: The First Commercial Validation Of The Blood-Brain Barrier Platform
seekingalpha.com
The moon is the ‘ULTIMATE HIGH GROUND': ICON Prime president
youtube.com
What's Going on With Lululemon Stock?
fool.com
What's Going on With UnitedHealth Stock?
fool.com
Great News for Taiwan Semiconductor Stock Investors
fool.com
Why Is Everyone Talking About Netflix Stock?
fool.com
What's Going on With SoFi Stock?
fool.com
About
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
William Lewis
Website
Adele DeeringSenior Vice President of Portfolio Strategy & Operational Excellence
Bryan DunnVice President of Investor Relations
William H. LewisPresident, Chief Executive Officer & Chairman